Clinical Trial Update: Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting the pharmacokinetics of a single intravenous dose of inositol in preterm infants; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Retinopathy of Prematurity

Drugs mentioned

• Inositol (inositol)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 2 | Status: COMPLETED